A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
This study wants to figure out which treatment, teclistamab or PVd/Kd, works better.
This study wants to figure out which treatment, teclistamab or PVd/Kd, works better.
*Third Opinion AI Generated Synopsis
Trial Summary
The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd.
The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: